
How do Phase 1 Clinical Trials for Cancer Drugs Work?
Razelle Kurzrock, MD, Chief, Division of Hematology and Oncology,UCSD…

NextGenU.org and the Prevention of Cancer
Erica Frank, MD, MPH, Professor and Canada Research Chair, University…

Targeted Therapy and/or Immunotherapy for Cancer
Paul R. Billings MD, PhD, Internist, Clinical Geneticist, and…

A Full House for Myeloma Therapy: What’s Next in the Cards?
Robert Orlowski, MD, PhD, Florence Maude Thomas Cancer Research…

Managing Metastatic Colorectal Cancer
Bassel El-Rayes, MD, Professor and Vice Chair for Clinical Research,…

Compassionate Use of Investigational Drugs
Arthur L Caplan, PhD Director, Division of Medical Ethics,…

Single Cell Biology in Cancer Research and Treatment
Gavin Gordon, PhD, Senior Director, Global Pharma & Clinical…

How to Initiate Treatment for Chronic Myelogenous Leukemia
Jerald P. Radich, MD, Director of the Molecular Oncology Lab…

Making NGS Work for Oncologists
Smruti Vidwans, PhD, Chief Science Officer at CollabRx
Q: Your…

Treating Metastatic Malignant Melanoma
Keith Flaherty, MD, Associate Professor of Medicine, Harvard…

Introducing a New CollabRx Blog
George D Lundberg, MD, Editor in Chief and Chief Medical Officer…